Welsh Family Loses Three to Same Brain Cancer Over Twenty Years

Family brain cancer claims three relatives in twenty years across Gwynedd.

Iola Williams lost her father, mother, and sister to the exact same aggressive brain tumour type over a two-decade span. The retired psychiatric nurse from Llanfrothen watched her father Billy die from glioblastoma in 2004, followed by her mother Eleanor a decade later, and her sister Helen in January 2024.

Glioblastoma stands as the most common and fastest-growing type of brain cancer, with about 3,200 people diagnosed across the UK each year. Only a third of patients survive past one year, and just 4% live for five years or more, Brain Tumour Research stated.

“My dad was diagnosed in 2004, my mum in 2014 and Helen in 2024,” Williams, 68, said. “Nothing has really changed.”

Decades of Diagnostic Sorrow

Billy fell ill in 2004 while gardening for a friend in the village, initially prompting fears of a stroke before hospital scans revealed multiple brain tumours. He worked as a groundsman at Morfa Bychan Golf Club near Porthmadog and passed away within weeks at home.

Eleanor developed a brain tumour a decade later after previous treatments for breast and lung cancer, dying from treatment-related complications. Helen received her glioblastoma diagnosis on her 56th birthday, choosing to forgo chemotherapy and radiotherapy to spend her final weeks at home, where she died 12 weeks later.

“All she wanted to do was go home,” Williams said.

Welsh Family Loses Three to Same Brain Cancer Over Twenty Years
Photo: yahoo.com

The Funding Crisis

Brain Tumour Research described the family’s sequence of losses as highly unusual, noting no known hereditary links connecting the three cases. Hugh Adams from Brain Tumour Research said it remains one of the most underfunded areas of cancer research.

“Brain tumours, sadly, are the biggest cancer killer of children and adults under the age of 40, and we need to invest in research to get closer to cures,” Adams said.

Central government and devolved administration research funding has historically sat below 1%, Adams added. Williams urged the Welsh government to allocate more resources toward research and patient support for the illness.

Welsh Health Strategy

A Welsh government spokesperson said that officials are developing a National Cancer Strategy for Wales to transform prevention, diagnosis, and treatment.

“We are sorry to hear of Iola’s loss, and we recognise how much this matters to everyone whose life has been affected by cancer,” a Welsh government spokesperson said.

Gwynedd Family Questions

  • 2004: Billy dies from glioblastoma within weeks of diagnosis.
  • 2014: Eleanor dies a decade later from cancer treatment complications.
  • 2024: Helen passes away 12 weeks after receiving her glioblastoma diagnosis.

Common Questions About Glioblastoma

What makes glioblastoma so dangerous?

Glioblastoma is an aggressive form of brain cancer with rapid growth rates and limited treatment options. Brain Tumour Research reports that only a third of patients survive past one year.

Are multiple family diagnoses common?

Charity officials confirmed that losing three members of one family to the same brain tumour type is highly unusual. Experts know of no hereditary makeup links connecting Billy, Eleanor, and Helen’s cases.

What changes are families demanding?

Williams is calling for increased funding, better treatment options, and improved access to clinical trials. She said that medical approaches have barely advanced since her father’s diagnosis 20 years ago.

Brain Tumour Research began as an informal partnership of regional charities under the United Brain Tumour Campaign in 2004. The Diana Ford Trust re-registered as Brain Tumour Research in 2008 and launched as a national charity in 2009.

It now funds a network of Centres of Excellence at universities including Portsmouth, Queen Mary University of London, Imperial College Healthcare NHS Trust and Plymouth University. The charity’s patron John Bercow established the first all-party parliamentary group for brain tumours in July 2005.

“We’re not aware of any links based on hereditary makeup,” Adams said.